BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15554392)

  • 1. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
    Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
    Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
    Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Asano T; Ueda T; Furukawa M; Koike N; Tanaka N; Todoroki T; Miwa M
    Int J Cancer; 2002 Mar; 98(3):427-34. PubMed ID: 11920595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
    Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
    Yamato T; Sasaki M; Watanabe Y; Nakanuma Y
    J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
    Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
    Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
    Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
    J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.
    Matsuda A; Higashi M; Nakagawa T; Yokoyama S; Kuno A; Yonezawa S; Narimatsu H
    Lab Invest; 2017 Sep; 97(9):1103-1113. PubMed ID: 28581490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel monoclonal antibody specific for sialylated MUC1 mucin.
    Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
    Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Onuki K; Sugiyama H; Ishige K; Kawamoto T; Ota T; Ariizumi S; Yamato M; Kadota S; Takeuchi K; Ishikawa A; Onodera M; Onizawa K; Yamamoto M; Miyoshi E; Shoda J
    J Gastroenterol; 2014 Apr; 49(4):702-14. PubMed ID: 23588887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
    Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
    Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal laminin-5gamma2 chain expression is associated with the wall-invasion pattern of gallbladder adenocarcinoma.
    Okada K; Kijima H; Imaizumi T; Hirabayashi K; Matsuyama M; Yazawa N; Oida Y; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Biomed Res; 2009 Feb; 30(1):53-62. PubMed ID: 19265264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis.
    Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
    Oncol Rep; 2001; 8(3):485-9. PubMed ID: 11295067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 expression in colorectal carcinoma: Clinicopathological correlation and prognostic significance.
    Díaz Del Arco C; Garré P; Molina Roldán E; Lorca V; Cerón Nieto MÁ; Fernández Aceñero MJ
    Rev Esp Patol; 2018; 51(4):204-209. PubMed ID: 30269770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 mucin expression in follicular dendritic cells and lymphoepithelial lesions of gastric mucosa-associated lymphoid tissue lymphoma.
    Taki C; Kitajima S; Sueyoshi K; Yonezawa S; Tanaka S; Sakoda K; Irimura T; Sato E; Goto M
    Pathol Int; 2002 Nov; 52(11):691-701. PubMed ID: 12685546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
    Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
    Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.